Eric Langer
Creating Effective Leachables and Extractables Testing: Whose Responsibility Is It?
April 20 by Eric LangerThe problem of leachables and extractables (L&E) in single-use devices continues to hound both suppliers and end-users, and remains one of the more challenging issues inhibiting regulatory accep...
Single-use Disposables are Future Proofing Biopharmaceutical Manufacturing
October 23 by Eric LangerBiopharmaceutical companies that get stuck with legacy technologies, including older stainless steel equipment, and older processes, end up watching as competitors transition to more efficient, cost...
Biopharma Suppliers’ Budgets Increase: Bellwether for Better Times
December 15 by Eric LangerParticipate in this year’s 9th Annual Report! Be part of the bio-industry’s most authoritative, comprehensive analysis! Participants contribute to industry benchmarking, are first to...
Single Use Device Adoption Impacted by Slow Standards Setting
October 10 by Eric LangerBioPlan Associates’ 8th Annual Report and Survey of Biopharmaceutical Manufacturing, 2011, identifies the growing need for standards to support rapidly emerging and evolving single use, dispos...
Higher Tech Outsourcing Repositions CMOs
September 07 by Eric LangerCMOs are providing more advanced outsourcing services to remain competitive, as economic pressures drive demands for greater productivity. In our current study, the 8th Annual Report and...
Single Use Bioreactors Lead in New Use and Market Penetration
August 08 by Eric LangerSingle use technologies are strong change agents in biopharma manufacturing. Disposable devices emerge once again as a top new technology of interest among the 352 surveyed biomanufacturers in B...
BioPharma Budget Bump—2011 Sees Spending Upswing
June 08 by Eric LangerBudgets for the biomanufacturing sector of biotech show a significant upswing from recent years’ freezes and cuts. In fact, respondents to BioPlan’s 8th Annual Report and Survey of...
Single Use Technologies Changing the Biomanufacturing Landscape
April 04 by Eric LangerDuring the past six years, single use systems and devices have emerged as a key change agent in the biomanufacturing landscape. Acceptance in R&D and scale-up has been driven by their effecti...
Need for Access to Enabling Technologies Drives Growth in the Contract Biomanufacturing Market
March 21 by Andrea CharlesEric S. Langer, Managing Partner, BioPlan Associates, joins Andrea Charles from Pharma IQ, to address how the contract manufacturing sector is adapting to the changing needs of pharma and biotech, t...